The most recent short interest data was recently released for the 12/29/2017 settlement date, and VBI Vaccines Inc (VBIV - Get Report) is one of the most shorted stocks of the Russell 3000, based on 6.89 "days to cover" versus the median component at 4.65. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then divided by the average daily volume, to express the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Ten Bargains You Can Buy Cheaper Than The Insiders Did »

In the case of VBI Vaccines Inc ( VBIV - Get Report), the total short interest at the 12/29/2017 settlement date was 850,420 shares, which compares to the average daily trading volume of just 123,511 shares, for a "days to cover" ratio of 6.89.

When short sellers eventually cover their positions, by definition there must be buying activity because a share that is currently sold short must be purchased to be covered. At the present levels of short interest, if from this point forward every single VBIV share traded represented a short position being closed, then at the average daily volume of 123,511 shares it would only be during the 7th trading day that every short position would be closed.

So it would stand to reason that should some unexpectedly good news come out, and short sellers did not have 7 days of patience but instead wanted to cover their short positions very suddenly, that situation could result in sending the stock higher until the higher price produces enough sellers to generate the necessary volume to close out those positions quickly.

VBI Vaccines Inc ( VBIV - Get Report) has something relatively rare for a stock with this much short interest, that being insiders taking the other side of the trade. Looking back over the trailing six month period, VBIV has seen 4 different instances of insider buying, as summarized by the table below:

Purchased Insider Title Shares Price/Share Value
08/10/2017 Jeff Baxter CEO, President 10,000 $3.28 $32,800.00
08/21/2017 Francisco Diaz-mitoma Chief Medical Officer 3,000 $3.17 $9,510.00
08/21/2017 Jeff Baxter CEO, President 10,000 $3.22 $32,200.00
10/26/2017 Advisors Llc Perceptive 3,100,000 $3.05 $9,455,000.00
10/30/2017 Steven Gillis Director 300,000 $3.05 $915,000.00
10/30/2017 Sam Chawla Director 3,100,000 $3.05 $9,455,000.00
10/30/2017 Health, INC. Opko 655,738 $3.05 $2,000,000.90
11/28/2017 Jeff Baxter CEO, President 15,000 $4.75 $71,250.00
12/12/2017 Jeff Baxter CEO, President 10,000 $3.89 $38,853.91

Below is a chart showing the "days to cover" for VBIV over time:

And looking at the chart below, VBIV's low point in its 52 week range is $3.04 per share, with $6.60 as the 52 week high point — that compares with a last trade of $4.07.

VBI Vaccines Inc  Moving Averages Chart

In recent trading, shares of VBI Vaccines Inc ( VBIV - Get Report) were changing hands at $4.07/share.